Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers.
about
Postoperative radiation in esophageal squamous cell carcinoma and target volume delineationPerioperative and Palliative Chemotherapy for Esophageal CancerEsophageal surgery in minimally invasive eraThe epidemiology, diagnosis, and treatment of Barrett's carcinomaReevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials Over the Past 20 YearsPostoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a review.CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamouPreoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma.Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma.Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer.Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis.Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer.Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis.Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus.Transplantation of tissue-engineered cell sheets for stricture prevention after endoscopic submucosal dissection of the oesophagus.Updated experiences with minimally invasive McKeown esophagectomy for esophageal cancer.Internet-based perioperative exercise program in patients with Barrett's carcinoma scheduled for esophagectomy [iPEP - study] a prospective randomized-controlled trialTolerance and dose-volume relationship of intrathoracic stomach irradiation after esophagectomy for patients with thoracic esophageal squamous cell carcinoma.Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study.The value of esophagectomy surgical apgar score (eSAS) in predicting the risk of major morbidity after open esophagectomy.Recurrence pattern of squamous cell carcinoma in the midthoracic esophagus: implications for the clinical target volume design of postoperative radiotherapy.Mapping patterns of nodal metastases in esophageal carcinoma: rethinking the clinical target volume for supraclavicular nodal irradiation.A phase III, multicenter randomized controlled trial of neo-adjuvant chemotherapy paclitaxel plus cisplatin versus surgery alone for stage IIA-IIIB esophageal squamous cell carcinoma.Results of neoadjuvant therapy followed by esophagectomy for patients with locally advanced thoracic esophageal squamous cell carcinoma.Neoadjuvant chemoradiotherapy for resectable esophageal cancer: an in-depth study of randomized controlled trials and literature review.Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management.Role of endoscopy to predict a leak after esophagectomy.Neoadjuvant chemoradiotherapy may increase the risk of severe anastomotic complications after esophagectomy with cervical anastomosis.Current treatment options for esophageal diseases.The physiotherapist and the esophageal cancer patient: from prehabilitation to rehabilitation.Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials.Perioperative outcomes of esophageal cancer surgery in a mid-volume institution in the era of centralization.Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer.Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone.Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival.Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer.Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity.Postoperative adjuvant therapy for resectable thoracic esophageal squamous cell carcinoma: a retrospective analysis of 426 cases.
P2860
Q26741018-15314590-8AE2-459B-9354-DC1FD4B40861Q26753865-7B7C2054-0216-4F98-8C56-F43ED2D72599Q26769068-615D44B5-46DA-446A-B289-EBBEB306D1ACQ27027149-FAFB4EA6-BF66-429F-968F-9CA662BA052FQ28081365-55B2B223-6265-49CA-A76A-151A47828E33Q30245279-74CAB8BB-BED6-49A0-A7FC-1474A2E05C16Q33850915-3460F688-5FF3-46BA-B87B-81B5C908570AQ33854805-AE6D3E12-34B8-47BB-AE43-112753779EF1Q34469077-FC734545-A8E6-447D-B839-3A0FE52901A2Q35375231-3F23AE3E-B813-493D-836E-7107C1200797Q36045600-F9391E0D-7FAC-43EE-83A6-DE6AC4DFCC73Q36149779-DF48E930-4D9D-4774-817B-FF5E3CD5DACFQ36150708-BBC02457-0363-4394-A3C1-3EC904D3B143Q36221479-ECE61EF1-1B69-4CEF-8720-70AEC124AFC7Q36222524-C5BD8E54-EF81-44CC-8274-2FB99239472FQ36346639-00FD4384-AEDA-40DB-9056-6DC4633DC844Q36350253-D4EC5CAD-91AE-4E1E-909C-DC052FEE858AQ36405632-5470D7CF-A5D2-437E-874F-5C168A344148Q36544823-1485C423-FD7A-4485-91FA-AC51C5AC0EB6Q36546095-2DFAFF44-AEBD-45BF-9287-D28C406EAA5EQ37121352-87DB30EA-1F9B-44A3-9632-59F8AC552D6AQ37337933-E867669A-B4E7-4237-90EC-3D47EE5FE079Q37528393-355319C7-EDB0-425E-ABB9-8C49ED27FC28Q37636956-1D5B4448-DA5F-4663-8ADA-F16C150A0E47Q37677652-9A739C62-0DAC-4F42-8F91-FF11F952691BQ38264442-EB8A2919-8E71-405F-87E5-FBEE74DC5253Q38367708-6B3F9A22-E5D6-483A-B048-0805A439B04FQ38831243-26BA79DF-3609-43BA-9B08-7EB78F77EEE7Q38836788-EDB33003-33DB-4B03-A271-715A3D09A1C8Q38889292-4EE4363D-E5F3-4A62-82C3-8C0BFEE74D29Q38890205-C60379B3-48A3-4DF5-9906-3473987E1C0BQ39013077-465EADB5-2B59-4DF1-ABAD-E319A50C8E86Q39093898-DFA57342-956A-4132-BD7C-124B898E0F8EQ39582802-C6512649-0A49-4AD3-BBD0-B7EA36250DB9Q39880183-A5FCC21F-999A-48AC-A074-4C5A098E11F5Q40060938-B78E73E3-5F1C-4232-B568-9DE873D7CD28Q40305149-BA1C3113-F231-49BC-A8DD-33AD1CED7215Q40473593-1CBA1FF4-E8F4-4B0D-804C-C946688FC1F1Q40510182-C2F11FEB-F58E-45E4-BBFC-4B4CA1F99AF1Q41722771-86046CC7-4D51-4A4D-A6FB-50A14B5CAE4D
P2860
Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Meta-analysis of postoperative ...... esophageal junctional cancers.
@en
type
label
Meta-analysis of postoperative ...... esophageal junctional cancers.
@en
prefLabel
Meta-analysis of postoperative ...... esophageal junctional cancers.
@en
P2093
P2860
P50
P356
P1476
Meta-analysis of postoperative ...... oesophageal junctional cancers
@en
P2093
P2860
P304
P356
10.1002/BJS.9418
P407
P577
2014-02-03T00:00:00Z